Biggest News Aggregation in the World
📰 Et Cest News

Et Cest News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Et Cest. Real-time updates on events, politics, business and more.

u-blox AG: u-blox reports first nine months 2023 revenue of CHF 436 million

U-blox AG / Key word(s): 9 Month figures u-blox AG: u-blox reports first nine months 2023 revenue of CHF 436 million 11-Oct-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pu...
United States Switzerland General Rafael Duarte Stephan Zizala Equity Group Inc News Service

EQS-News: Wienerberger AG: wienerberger presents innovative solutions at Capital Markets Day 2023 in Belgium

EQS-News: Wienerberger AG / Key word(s): Conference/Sustainability Wienerberger AG: wienerberger presents innovative solutions at Capital Markets Day 2023 in Belgium 11.10.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. wienerberger presents innovativ...
United States Bruxelles Capitale Heimo Scheuch Claudia Hajdinyak South Eastern Europe Head Of Corporate Communications Wienerberger

EQS-News: PlusPlus announces terms of Buyback offer for EUR 2022/2026 Bonds

EQS-News: PlusPlus Capital Financial S.à.r.l. / Key word(s): Bond PlusPlus announces terms of Buyback offer for EUR 2022/2026 Bonds 11.10.2023 / 14:30 CET/CEST The issuer is solely responsible for the content of this announcement. PlusPlus announces terms of Buyback offer for EUR 2022/2026 Bonds...
Vilniaus Apskritis Eteläuomen Läi Jean Piret Kaarel Raik News Service Distribution Services

EQS-News: Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023: The 9th Joint ECTRIMS-ACTRIMS Meeting

Issuer: Immunic, Inc. / Key word(s): Study results/Conference Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023: The 9th Joint ECTRIMS-ACTRIMS Meeting 11.10.2023 / 12:30 CET/CEST The issuer is solely responsible for...
United States Edna Kaplan Paula Schwartz Jessica Breu Robertj Fox Daniel Vitt

u-blox AG: u-blox introduces new functionally safe end-to-end positioning solution for autonomous driving

U-blox AG / Key word(s): Product Launch u-blox AG: u-blox introduces new functionally safe end-to-end positioning solution for autonomous driving 10.10.2023 / 09:00 CET/CEST u-blox introduces new functionally safe end-to-end positioning solution for autonomous driving u-blox u-safe is a pre-cert...
Switzerland General United States Natacha Seitz Peter Kalinowski Thingstream Io News Service

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Nordea Bank Abp: Transaction in Own Shares

Nordea Bank Abp / Key word(s): Transaction in Own Shares Nordea Bank Abp: Transaction in Own Shares 10.10.2023 / 08:00 CET/CEST Nordea Bank Abp: Repurchase of own shares on 09.10.2023 Nordea Bank Abp Stock exchange release - Changes in company's own shares 09.10.2023 at 22.30 EET Nordea Bank Abp...
City Of United Kingdom Morgan Stanley Europe Nordea Bank Abp News Service Nordea Bank Abp Key

Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone

Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone 10-Oct-2023 / 07:00 CET/CEST Release of an ad hoc a...
Switzerland General Jeremy Meinen Jack Weinstein Relief Therapeutics Holding Swiss Exchange Exchange Commission

IGEA Pharma N.V.: IGEA to update on RBCARE business combination

IGEA Pharma N.V. / Key word(s): Letter of Intent/Letter of Intent IGEA Pharma N.V.: IGEA to update on RBCARE business combination 09-Oct-2023 / 22:50 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement.     FOR R...
Noord Holland United Kingdom District Of Columbia United States Pierpaolo Cerani News Service

EQS-News: Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

Issuer: Immunic, Inc. / Key word(s): Study results Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis 09.10.2023 / 22:01 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Reports Positi...
United States Andreas Muehler Jessica Breu Edna Kaplan Jens Kuhle Paula Schwartz

EQS-News: Steinhoff International Holdings N.V. in liquidatie: DE-LISTING TIMELINE

EQS-News: Steinhoff International Holdings N.V. in liquidatie / Key word(s): Miscellaneous Steinhoff International Holdings N.V. in liquidatie: DE-LISTING TIMELINE 10.10.2023 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement. Shareholders are referred to the ...
South Africa Western Cape Adam Tas Tradegate Exchange Steinhoff International Holdings Frankfurt Stock Exchange

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science